Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index; 40 of the 148 sources its claims cite were checked for support.

Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission

Open access

Abstract

Aims/hypothesis: Weight reduction is fundamental for type 2 diabetes management and remission, but uncertainty exists over which diet type is best to achieve and maintain weight loss. We evaluated dietary approaches for weight loss, and remission, in people with type 2 diabetes to inform practice and clinical guidelines. Methods: First, we conducted a systematic review of published meta-analyses of RCTs of weight-loss diets. We searched MEDLINE (Ovid), PubMed, Web of Science and Cochrane Database of Systematic Reviews, up to 7 May 2021. We synthesised weight loss findings stratified by diet types and assessed meta-analyses quality with A Measurement Tool to Assess Systematic Reviews (AMSTAR) 2. We assessed certainty of pooled results of each meta-analysis using Grading of Recommendations, Assessment, Development and Evaluations (GRADE) (PROSPERO CRD42020169258). Second, we conducted a systematic review of any intervention studies reporting type 2 diabetes remission with weight-loss diets, in MEDLINE (via PubMed), Embase and Cochrane Central Register of Controlled Trials, up to 10 May 2021. Findings were synthesised by diet type and study quality (Cochrane Risk of Bias tool 2.0 and Risk Of Bias In Non-randomised Studies – of Interventions [ROBINS-I]), with GRADE applied (PROSPERO CRD42020208878). Results: We identified 19 meta-analyses of weight-loss diets, involving 2–23 primary trials ( n = 100–1587), published 2013–2021. Twelve were ‘critically low’ or ‘low’ AMSTAR 2 quality, with seven ‘high’ quality. Greatest weight loss was reported with very low energy diets, 1.7–2.1 MJ/day (400–500 kcal) for 8–12 weeks (high-quality meta-analysis, GRADE low), achieving 6.6 kg (95% CI −9.5, −3.7) greater weight loss than low-energy diets (4.2–6.3 MJ/day [1000–1500 kcal]). Formula meal replacements (high quality, GRADE moderate) achieved 2.4 kg (95% CI −3.3, −1.4) greater weight loss over 12–52 weeks. Low-carbohydrate diets were no better for weight loss than higher-carbohydrate/low-fat diets (high quality, GRADE high). High-protein, Mediterranean, high-monounsaturated-fatty-acid, vegetarian and low-glycaemic-index diets all achieved minimal (0.3–2 kg) or no difference from control diets (low to critically low quality, GRADE very low/moderate). For type 2 diabetes remission, of 373 records, 16 met inclusion criteria. Remissions at 1 year were reported for a median 54% of participants in RCTs including initial low-energy total diet replacement (low-risk-of-bias study, GRADE high), and 11% and 15% for meal replacements and Mediterranean diets, respectively (some concerns for risk of bias in studies, GRADE moderate/low). For ketogenic/very low-carbohydrate and very low-energy food-based diets, the evidence for remission (20% and 22%, respectively) has serious and critical risk of bias, and GRADE certainty is very low. Conclusions/interpretation: Published meta-analyses of hypocaloric diets for weight management in people with type 2 diabetes do not support any particular macronutrient profile or style over others. Very low energy diets and formula meal replacement appear the most effective approaches, generally providing less energy than self-administered food-based diets. Programmes including a hypocaloric formula ‘total diet replacement’ induction phase were most effective for type 2 diabetes remission. Most of the evidence is restricted to 1 year or less. Well-conducted research is needed to assess longer-term impacts on weight, glycaemic control, clinical outcomes and diabetes complications. Graphical abstract:

Overview

CoChat Summary

TL;DR

This umbrella review of meta-analyses and systematic review of remission trials found no clear superiority of any macronutrient profile or diet style for weight loss in adults with type 2 diabetes. Very low energy diets and formula meal replacement produced greater weight loss, and total diet replacement programmes were most effective for type 2 diabetes remission, but most evidence was limited to ≤1 year.

Key findings

  • In 19 meta-analyses (2–23 primary trials; n = 100–1587), very low energy diets (1.7–2.1 MJ/day [400–500 kcal] for 8–12 weeks) achieved 6.6 kg greater weight loss than low-energy diets (95% CI −9.5, −3.7; high-quality meta-analysis, GRADE low). Formula meal replacements achieved 2.4 kg greater weight loss over 12–52 weeks (95% CI −3.3, −1.4; high quality, GRADE moderate).
  • Low-carbohydrate diets were no better for weight loss than higher-carbohydrate/low-fat diets (high quality, GRADE high). High-protein, Mediterranean, high-monounsaturated-fatty-acid, vegetarian and low-glycaemic-index diets all achieved minimal (0.3–2 kg) or no difference from control diets (low to critically low quality, GRADE very low/moderate).
  • For remission, 16 studies met inclusion criteria. At 1 year, median 54% remission (range 46–61%) was reported in RCTs including initial low-energy total diet replacement versus 4–12% in usual care (N = 445, 2 RCTs; GRADE high). Meal replacement achieved 11% versus 2% (N = 4503; GRADE moderate/low), and Mediterranean diet achieved 15% versus 4% (N = 215; GRADE low). Ketogenic/very low-carbohydrate and very low-energy food-based diets reported 20% and 22% remission, respectively, with serious/critical risk of bias and GRADE very low certainty.
  • Single-arm/non-randomised studies reported higher remission than RCTs; shorter type 2 diabetes duration and Asian ethnicity were associated with greater likelihood of remission. Adherence up to 1 year was poorer with very low-carbohydrate diets (<50 g carbohydrate) than with low-carbohydrate diets (<130 g carbohydrate).

Methods

  • Umbrella review of published meta-analyses of RCTs of weight-loss diets in type 2 diabetes; searched MEDLINE (Ovid), PubMed, Web of Science and Cochrane Database of Systematic Reviews to 7 May 2021; quality assessed with AMSTAR 2 and certainty with GRADE (PROSPERO CRD42020169258).
  • Systematic review of any intervention studies reporting type 2 diabetes remission with weight-loss diets; searched MEDLINE (via PubMed), Embase and Cochrane Central Register of Controlled Trials to 10 May 2021; included RCTs and non-randomised studies, assessed with Cochrane Risk of Bias 2.0 and ROBINS-I, and GRADE (PROSPERO CRD42020208878). Findings were synthesised by diet type without meta-analysis due to limited and heterogeneous studies; intention-to-treat remission was computed when only completer data were reported.

Limitations

  • The paper states that many included meta-analyses were of low or critically low AMSTAR 2 quality, predominantly because no protocol was reported and publication bias was not assessed; many had fewer than ten RCTs, limiting funnel-plot assessment. AMSTAR 2 criteria can be subjective, and if relaxed for protocol reporting and publication bias, the meta-analyses allow some confidence in the consistent findings of little/no difference between diets.
  • The paper states that most included studies were in European participants, so results may not apply equally to other ethnic and/or deprived communities; South Asians may be more sensitive to weight loss. It also notes insufficient detail on macronutrient/micronutrient contents and prescribed/reported energy intakes, varied control diets, varied intervention durations, and that most evidence relates to ≤1 year.
  • Evident from the text: remission evidence is limited, with only two RCTs having remission as the pre-specified outcome; many non-randomised studies had critical risk of bias, lacked comparator groups and/or randomisation, and may retain residual confounding. Some studies did not routinely withdraw glucose-lowering medications, so only minimum remissions can be reported, and no RCT evaluated low-carbohydrate/ketogenic diets for remission.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00125-021-05577-2

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Summary of the methodological processes of both systematic reviews. Detailed methods are presented in the ESM Methods. aThese types of NRSs provided intervention to participants and assessed outcomes at designated specific time points (baseline and at the end of intervention), although they could suffer from selection bias and confounding bias. bAMSTAR 2 level of quality assessment: high quality—the meta-analysis provides an accurate and comprehensive summary of the results of the available studies that addresses the question of interest; moderate—the meta-analysis has more than one weakness, but no critical flaws. It may provide an accurate summary of the results of the available studies; low—the meta-analysis has a critical flaw and may not provide an accurate and comprehensive summary of the available studies that address the question of interest; or critically low—the meta-analysis has more than one critical flaw and should not be relied on to provide an accurate and comprehensive summary of the available studies. CENTRAL, Cochrane Central Register of Controlled Trials; ROBINS-I, Risk Of Bias In Non-randomised Studies – of Interventions; T2D, type 2 diabetes
Fig. 1 Summary of the methodological processes of both systematic reviews. Detailed methods are presented in the ESM Methods. aThese types of NRSs provided intervention to participants and assessed outcomes at designated specific time points (baseline and at the end of intervention), although they could suffer from selection bias and confounding bias. bAMSTAR 2 level of quality assessment: high quality—the meta-analysis provides an accurate and comprehensive summary of the results of the available studies that addresses the question of interest; moderate—the meta-analysis has more than one weakness, but no critical flaws. It may provide an accurate summary of the results of the available studies; low—the meta-analysis has a critical flaw and may not provide an accurate and comprehensive summary of the available studies that address the question of interest; or critically low—the meta-analysis has more than one critical flaw and should not be relied on to provide an accurate and comprehensive summary of the available studies. CENTRAL, Cochrane Central Register of Controlled Trials; ROBINS-I, Risk Of Bias In Non-randomised Studies – of Interventions; T2D, type 2 diabetesCC BY · PubMed Central
Fig. 2 All published meta-analyses of intervention diets vs control diets on weight loss (kg) stratified by overall quality in each diet type using AMSTAR 2 quality (green, high quality; orange, low quality; red, critically low quality). WMDs are presented alongside 95% CIs (error bars). Pooled results of McArdle et al., 2019 [34], Fan et al., 2016 [27], Zafar et al., 2019 [36] and Zhao et al., 2018 [30] are standardised mean differences. aComplete case data. GRADE level for certainty of evidence is rated as follows: ‘high’ indicates that we are very confident that the true effect lies close to that of the estimate of the effect; ‘moderate’ indicates that we are moderately confident in the effect estimate (the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different); ‘low’ indicates that our confidence in the effect estimate is limited (the true effect may be substantially different from the estimate of the effect); and ‘very low’ indicates that we have very little confidence in the effect estimate (the true effect is likely to be substantially different from the estimate of effect)
Fig. 2 All published meta-analyses of intervention diets vs control diets on weight loss (kg) stratified by overall quality in each diet type using AMSTAR 2 quality (green, high quality; orange, low quality; red, critically low quality). WMDs are presented alongside 95% CIs (error bars). Pooled results of McArdle et al., 2019 [34], Fan et al., 2016 [27], Zafar et al., 2019 [36] and Zhao et al., 2018 [30] are standardised mean differences. aComplete case data. GRADE level for certainty of evidence is rated as follows: ‘high’ indicates that we are very confident that the true effect lies close to that of the estimate of the effect; ‘moderate’ indicates that we are moderately confident in the effect estimate (the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different); ‘low’ indicates that our confidence in the effect estimate is limited (the true effect may be substantially different from the estimate of the effect); and ‘very low’ indicates that we have very little confidence in the effect estimate (the true effect is likely to be substantially different from the estimate of effect)CC BY · PubMed Central
Fig. 3 Meta-analyses with source RCTs of 12 months or longer on weight loss (kg) outcome. WMDs are presented alongside 95% CIs (error bars). Different colours indicate meta-analysis quality: green, high quality; red, critically low quality. GRADE level for certainty of evidence: ‘high’ indicates that we are very confident that the true effect lies close to that of the estimate of the effect; ‘moderate’ indicates that we are moderately confident in the effect estimate (the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different); ‘low’ indicates that our confidence in the effect estimate is limited (the true effect may be substantially different from the estimate of the effect); and ‘very low’ indicates that we have very little confidence in the effect estimate (the true effect is likely to be substantially different from the estimate of effect)
Fig. 3 Meta-analyses with source RCTs of 12 months or longer on weight loss (kg) outcome. WMDs are presented alongside 95% CIs (error bars). Different colours indicate meta-analysis quality: green, high quality; red, critically low quality. GRADE level for certainty of evidence: ‘high’ indicates that we are very confident that the true effect lies close to that of the estimate of the effect; ‘moderate’ indicates that we are moderately confident in the effect estimate (the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different); ‘low’ indicates that our confidence in the effect estimate is limited (the true effect may be substantially different from the estimate of the effect); and ‘very low’ indicates that we have very little confidence in the effect estimate (the true effect is likely to be substantially different from the estimate of effect)CC BY · PubMed Central
Fig. 4 Percentage of remissions of type 2 diabetes at 12 months after intervention with different diet types, stratified by study design and risk of bias. Each dot, with varying shapes to reflect risk of bias, indicates the data point for each of the studies mentioned in the main text which provided data in this form at 12 months. The column represents the mean for the diet type. Remission was defined as either HbA1c < 48 mmol/mol (<6.5%) or fasting plasma glucose <7 mmol/l, with no glucose-lowering medication. Total diet replacement programmes included an initial low-energy formula diet, prescribed for an 8–12 week induction phase, followed by stepped food re-introduction aimed to achieve energy balance for weight loss maintenance. VLED advised a 2.9 MJ (700 kcal) food-based diet for 1 week, then dietary advice for energy intake that matched for ideal body weight. Very low-carbohydrate ketogenic diet was ad libitum intake, carbohydrate <30 g/day to achieve ketosis and 3–5 servings of non-starchy vegetables. Usual diet or standard diet interventions included diabetes education support, but no new diet intervention
Fig. 4 Percentage of remissions of type 2 diabetes at 12 months after intervention with different diet types, stratified by study design and risk of bias. Each dot, with varying shapes to reflect risk of bias, indicates the data point for each of the studies mentioned in the main text which provided data in this form at 12 months. The column represents the mean for the diet type. Remission was defined as either HbA1c < 48 mmol/mol (<6.5%) or fasting plasma glucose <7 mmol/l, with no glucose-lowering medication. Total diet replacement programmes included an initial low-energy formula diet, prescribed for an 8–12 week induction phase, followed by stepped food re-introduction aimed to achieve energy balance for weight loss maintenance. VLED advised a 2.9 MJ (700 kcal) food-based diet for 1 week, then dietary advice for energy intake that matched for ideal body weight. Very low-carbohydrate ketogenic diet was ad libitum intake, carbohydrate <30 g/day to achieve ketosis and 3–5 servings of non-starchy vegetables. Usual diet or standard diet interventions included diabetes education support, but no new diet interventionCC BY · PubMed Central

Verification

Claims the paper makes

17 Valid · 3 Not valid · 61 Not checked · 85 Own results and interpretations

91 more claims · 8 with their cited sources checked

Create a free account to see all 166 claims and to verify the 108 references still open.

See all claims — free account
  • Probably not a substantial claim. 32
  • It may state two separate claims as one. 46

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 7 · the rest aren’t loaded

2 more findings

Create a free account to see every finding of this check.

See all findings — free account

Citations

Cites

Show all 105 references

Research works printed but not linked: 1

  1. Fan YF, Di HJ, Chen GF, Mao XD, Liu C (2016) Effects of low carbohydrate diets in individuals with type 2 diabetes: systematic review and meta-analysis. Int J Clin Exp Med 9(6):11166–11174

Cited by

See all 236

Metadata

Authors
Churuangsuk, C., Hall, J., Reynolds, A., Griffin, S. J., Combet, E., & Lean, M. E. J.
Affiliations
  • Prince of Songkla University (TH)
  • University of Glasgow (GB)
  • University of Otago (NZ)
  • University of Cambridge (GB)
Corresponding author
Lean, Michael E. J.
Venue
Diabetologia
Published
2021-11-17
Volume
65
Issue
1
Pages
14-36
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W3191307854
Cited by
204
References
105
Citations by year
2026: 27 · 2025: 55 · 2024: 47 · 2023: 44 · 2022: 29 · 2021: 1
FWCI
4.04
Type
journal article
Language
en
Open access
Licence
Locations
  • Diabetologia (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo (cc-by)
Funders
  • National Institute for Health and Care Research
  • University of Glasgow
Topics
  • Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
Keywords
type 2 diabetes, weight loss diet, diabetes remission, weight management, very low calorie diet, hypocaloric diet, low-carbohydrate diet, low-fat diet, Mediterranean diet
MeSH terms
Systematic Reviews as Topic, Adult, Clinical Trials as Topic, Diabetes Mellitus, Type 2, Humans, Meta-Analysis as Topic, Weight Loss, Diet, Fat-Restricted, Diet, Carbohydrate-Restricted

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission. https://app.cochat.ai/papers/10.1007/s00125-021-05577-2
The paper
Churuangsuk, C., Hall, J., Reynolds, A., Griffin, S. J., Combet, E., & Lean, M. E. J. (2022). Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission. Diabetologia. https://doi.org/10.1007/s00125-021-05577-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.